2care4 Generics ApS: Financial statements 2019
CVR: 36960566
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
2care4 Generics ApS (CVR 36960566) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 7,988,765 and a net result of DKK -599,230 compared with DKK -2,896,734 the year before. That is an increase of 145% compared with the year before. Equity in the 2019 report amounted to DKK -165,565. The company had 8 employees in the financial year.
- Gross Profit
- DKK 7,988,765
- Profit/Loss
- DKK -599,230
- Equity
- DKK -165,565
- Total Assets
- DKK 35,416,678
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 8 mio. | -599 t. | -166 t. | 8 |
| 2018 | - | 3.3 mio. | -2.9 mio. | 434 t. | 7 |
| 2017 | - | -1.5 mio. | -6 mio. | 330 t. | 5 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of September 6, 2019, Torben Børsting has stepped down as director of 2care4 Generics ApS.
2care4 Generics ApS has published its annual report for 2018. Gross profit came to DKK 3,260,793, and the net result was DKK -2,896,734.
As of May 1, 2019, Torben Børsting has left the board of directors of 2care4 Generics ApS.
As of May 1, 2019, Ulrik Ernst Rasmussen is registered as adm. dir. of 2care4 Generics ApS.
As of May 1, 2019, Toke Værndal has stepped down as adm. dir. of 2care4 Generics ApS.
About 2care4 Generics ApS
2care4 Generics ApS is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Erik Sandberg. The board consists of Toke Værndal. The company is owned by 2care4 Group ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 52,415,000 and a net result of DKK 11,207,000 compared with DKK 17,193,000 the year before. Equity in the 2025 report amounted to DKK 49,944,000.